Semaglutide reduces MACE in patients with obesity or overweight and prior CABG
Heart MattersSemaglutide reduces MACE in patients with obesity or overweight and prior CABG
Tirzepatide reduces HF events in patients with HFpEF and obesity
Heart MattersTirzepatide reduces HF events in patients with HFpEF and obesity
A Deep Dive into the Pathophysiology of CAH and Its Impact on Treatment
Clinician's RoundtableA Deep Dive into the Pathophysiology of CAH and Its Impact on Treatment
Evaluating Endocrine Complications in DMD Patients: Findings from a Survey
NeuroFrontiersEvaluating Endocrine Complications in DMD Patients: Findings from a Survey
Navigating Complex CAH Care from Newborn to Adult
Clinician's RoundtableNavigating Complex CAH Care from Newborn to Adult
Managing Patients with Congenital Adrenal Hyperplasia
Clinician's RoundtableManaging Patients with Congenital Adrenal Hyperplasia
- 3 questions
Expert Insights on Congenital Adrenal Hyperplasia Care From an Adult Endocrinologist
Medical Industry FeatureExpert Insights on Congenital Adrenal Hyperplasia Care From an Adult Endocrinologist
Expert Insights on Adult Congenital Adrenal Hyperplasia Care
Medical Industry FeatureExpert Insights on Adult Congenital Adrenal Hyperplasia Care
Rethinking Diabetes Care: Key Data from Incorporating Lifestyle Modifications
Medical Industry FeatureRethinking Diabetes Care: Key Data from Incorporating Lifestyle Modifications
- 03/20/2025
- 03/20/2025
- 03/19/2025
- 03/19/2025
- 03/18/2025
- 03/17/2025